Gene Tests in Sudden Cardiac Death Victims Cambridge MA

Genetic testing of people who've suffered sudden unexplained death is an effective and cost-efficient way of identifying genetic mutations that may put surviving relatives at increased risk for potentially deadly heart rhythm disturbances, a new study suggests.

David E Schwartz, MD
(978) 927-4110
77 Herrick St
Beverly, MA
Business
The Medical Group Inc
Specialties
Cardiology

Data Provided by:
William Robert Bachman
(617) 591-4350
230 Highland Ave
Somerville, MA
Specialty
Cardiology, Internal Medicine, Cardiovascular Disease

Data Provided by:
Thomas Aaron Risser, MD
(617) 665-1025
1493 Cambridge St
Cambridge, MA
Specialties
Cardiology, Internal Medicine
Gender
Male
Education
Medical School: Pa State Univ Coll Of Med, Hershey Pa 17033
Graduation Year: 1972
Hospital
Hospital: Cambridge Hosp, Cambridge, Ma; Mount Auburn Hospital, Cambridge, Ma

Data Provided by:
Thomas Aaron Risser
(617) 665-1025
1493 Cambridge St
Cambridge, MA
Specialty
Cardiology, Internal Medicine, Critical Care (Intensivists), Cardiovascular Disease

Data Provided by:
Collin Melveton Stultz, MD
32 Vassar St
Cambridge, MA
Specialties
Cardiology
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1997

Data Provided by:
Marcus Patrick Cooper, MD
(617) 444-2365
35 Landsdowne St
Cambridge, MA
Specialties
Cardiology
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1999

Data Provided by:
James Kuang-Jan Liao, MD
(617) 768-8424
65 Landsdowne St Rm 275
Cambridge, MA
Specialties
Cardiology
Gender
Male
Education
Medical School: Univ Of Ca, San Francisco, Sch Of Med, San Francisco Ca 94143
Graduation Year: 1985

Data Provided by:
Ingo H Stubbe
(617) 591-4920
230 Highland Ave
Somerville, MA
Specialty
Cardiology, Internal Medicine

Data Provided by:
William Paul Dole, MD
(510) 669-4047
400 Technology Sq Ste 8
Cambridge, MA
Specialties
Cardiology
Gender
Male
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1973

Data Provided by:
George A Theodosiou, MD
(508) 793-6617
931 Massachusetts Ave Apt 1002
Cambridge, MA
Specialties
Cardiology
Gender
Male
Education
Medical School: Inst De Med Si Farm, Carol Davila, Bucharest, Romania
Graduation Year: 1962

Data Provided by:
Data Provided by:

Gene Tests in Sudden Cardiac Death Victims

Provided By:

SUNDAY, Nov. 15 (HealthDay News) -- Genetic testing of people who've suffered sudden unexplained death is an effective and cost-efficient way of identifying genetic mutations that may put surviving relatives at increased risk for potentially deadly heart rhythm disturbances, a new study suggests.

Genetic defects that can cause sudden cardiac death occur in 25 percent to 30 percent of victims of sudden unexplained death. The current recommended approach is for first-degree relatives of sudden unexplained death victims to undergo comprehensive cardiac testing.

In this study, U.S. researchers compared the results and costs of postmortem genetic/molecular autopsy testing in 146 sudden unexplained death cases and found that 40 of the victims (26.7 percent) had either a catecholaminergic polymorphic ventricular tachycardia mutation (18 people) or a long QT syndrome mutation (22 people). Both are known to cause sudden death.

The researchers then estimated the costs of testing the 584 relatives of the sudden unexplained death victims. The total cost of postmortem genetic testing, genetic confirmation testing of the 160 relatives of victims who tested positive for mutations, and cardiac tests for both relatives of mutation-positive and mutation-negative sudden unexplained death victims was $6.78 million.

In comparison, comprehensive cardiac testing for all 584 relatives of the sudden unexplained death victims, followed by directed genetic testing, would have been more than $7.7 million.

"With less than 150 sudden unexplained death cases, use of a cardiac channel molecular autopsy would be estimated to save almost $1 million indicating a much less expensive way of evaluating those left behind," study co-author David Tester, a senior research technologist at Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minn., said in a news release.

"If you identify a mutation in a sudden unexplained death victim, you can do a simple genetic test in first-degree relatives to assess their risk and perform a disorder-directed clinical evaluation rather than a full clinical evaluation. If a relative is negative for the causative mutation, they may not need to undergo further clinical evaluation at all, and that saves money," Tester explained.

The study was to be presented Sunday at the American Heart Association's annual meeting in Orlando, Fla.

More information

The U.S. National Heart, Lung, and Blood Institute has more about sudden cardiac arrest.

SOURCE: American Heart Association, news release, Nov. 15, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com